| Product NDC: | 67457-219 |
| Proprietary Name: | Duraclon |
| Non Proprietary Name: | clonidine hydrochloride |
| Active Ingredient(s): | .5 mg/mL & nbsp; clonidine hydrochloride |
| Administration Route(s): | EPIDURAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67457-219 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020615 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961002 |
| Package NDC: | 67457-219-10 |
| Package Description: | 1 VIAL in 1 CARTON (67457-219-10) > 10 mL in 1 VIAL |
| NDC Code | 67457-219-10 |
| Proprietary Name | Duraclon |
| Package Description | 1 VIAL in 1 CARTON (67457-219-10) > 10 mL in 1 VIAL |
| Product NDC | 67457-219 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clonidine hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | EPIDURAL |
| Start Marketing Date | 19961002 |
| Marketing Category Name | NDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |